Wells Fargo’s Centessa Pharmaceuticals CNTA Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$1.97K	Sell	150 -31,296	-100%	-$411K	﹤0.01%	5756
2025 Q1	$452K	Buy	+31,446	New	+$452K	﹤0.01%	3748
2024 Q3	–	Sell	-520	Closed	-$4.7K	–	6505
2024 Q2	$4.7K	Buy	+520	New	+$4.7K	﹤0.01%	5499